Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice-Reference-Cited by-同舟云学术

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice

Published:2010-04 Issue:4 Volume:48 Page:789-798
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Braunersreuther Vincent,Pellieux Corinne,Pelli Graziano,Burger Fabienne,Steffens Sabine,Montessuit Christophe,Weber Christian,Proudfoot Amanda,Mach François,Arnaud Claire

Funder

EU FP7

AtheroRemo, the Swiss National Science Foundation

Foundation for Medical Researches

Foundation for Medical Research

Agir à Dom

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference38 articles.

1. Coronary reperfusion following experimental myocardial infarction;Kloner;J. Card. Surg.,1987

2. Mechanisms of myocardial reperfusion injury;Park;Ann. Thorac. Surg.,1999

3. The inflammatory response in myocardial infarction;Frangogiannis;Cardiovasc. Res.,2002

4. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease;Entman;Cardiovasc. Res.,1994

5. Status of myocardial antioxidants in ischemia-reperfusion injury;Dhalla;Cardiovasc. Res.,2000

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review;Pharmacological Research;2024-08

2. CCR5 and inflammatory storm;Ageing Research Reviews;2024-04

3. Role of neutrophils in different stages of atherosclerosis;Innate Immunity;2023-07-25

4. Efficacy Screening of Prospective Anti-allergic Drug Candidates: An In silico Study;Current Bioinformatics;2023-02

5. Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway;Drug Design, Development and Therapy;2022-12